Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedAdds a government-operating-status notice and upgrades the software version from v3.1.0 to v3.2.0; the legacy v3.1.0 is removed.SummaryDifference4%

- Check35 days agoChange DetectedUpgrade from v3.0.2 to v3.1.0, indicating updated software/features.SummaryDifference0.1%

- Check49 days agoChange DetectedIncremented revision from v3.0.1 to v3.0.2 and removed the Back to Top element.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check64 days agoChange DetectedThe webpage has been updated to include new facility names and locations, as well as specific drug information regarding efgartigimod alfa. Additionally, the revision number has been updated to v3.0.0.SummaryDifference7%

- Check78 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.